Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02353078 · ClinicalTrials.gov registry record · Early Phase 1
The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis
A Early Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 3
- Enrollment target
NCT02353078: Completed Early Phase 1 study, sponsored by Mayo Clinic.
NCT02353078 is a Early Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 3 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02353078, a Early Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
Could Sucralfate be a non-steriodal treatment option for patients with Eosinophilic esophagitis?
Primary Outcome
• The effect treatment is defined by 50%, 3 of the 6 patients having less \< 15 eosinophilia per high power field by in the pathology at the time of follow up endoscopic biopsies.
Interventions
- DRUG Sucralfate
- PROCEDURE Intraluminal Impedance
- DEVICE Intraluminal Impedance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-12 |
| Phase | Early Phase 1 |
What the finished NCT02353078 record still lists
NCT02353078 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Sucralfate is the first listed.
NCT02353078 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02353078 about?
NCT02353078 is a clinical study titled "The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis". Could Sucralfate be a non-steriodal treatment option for patients with Eosinophilic esophagitis?
What is the current status of trial NCT02353078?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 3 participants. The study started on 2015-01. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02353078?
The interventions under investigation include: Sucralfate (DRUG), Intraluminal Impedance (PROCEDURE), Intraluminal Impedance (DEVICE).
Who is sponsoring clinical trial NCT02353078?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02353078's enrollment target sits among peer trials
3 1949th of 2000 higher than 28 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia